Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using P53 activator and c-Met inhibitor

Combination therapy using P53 activator and c-Met inhibitor

US Patent 10188647 · Granted Jan 29, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarker PNCK for predicting effect of a dual-targeting agent2020
Prediction of effect of a c-Met inhibitor using mutation of KRAS or BRAF2019
Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibit2018
Traffic distribution in heterogenous network environment2018
Biomarker Hsp90 for predicting effect of a c-Met inhibitor2018
Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor2018
Method of combination therapy for prevention or treatment of c-Met or angiogenes2018
PDGF as a biomarker for predicting resistance or effect of c-Met targeting drugs2018
Biomarker TFF1 for predicting effect of C-MET inhibitor2017
Anti-c-Met/anti-Ang2 bispecific antibody2017
Method of combination therapy using an anti-C-Met antibody2017
Method of combination therapy using an anti-C-Met antibody2017